We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.04B
Cap. Flow %
8.47%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPAY
2851
DELISTED
FlexShopper
FPAY
$125K ﹤0.01%
+40,317
New +$110K
FTEK icon
2852
Fuel Tech
FTEK
$43.7M
$124K ﹤0.01%
71,543
-48,318
-40% -$91.5K
CERS icon
2853
Cerus
CERS
$516M
$123K ﹤0.01%
+20,163
New +$118K
XYF
2854
X Financial
XYF
$206M
$123K ﹤0.01%
+29,681
New +$203K
TAC icon
2855
TransAlta
TAC
$3.95B
$121K ﹤0.01%
11,468
-227,149
-95% -$2.28M
IGV icon
2856
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
$120K ﹤0.01%
1,500
-274,000
-99% -$22.4M
TRON
2857
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
$120K ﹤0.01%
+12,171
New +$119K
PIII icon
2858
P3 Health Partners
PIII
$41.1M
$119K ﹤0.01%
+240
New +$118K
PRPH
2859
DELISTED
ProPhase Labs
PRPH
$119K ﹤0.01%
+2,280
New +$136K
AXLA
2860
DELISTED
Axcella Health Inc. Common Stock
AXLA
$119K ﹤0.01%
1,601
-1,296
-45% -$111K
CVS icon
2861
PUT
CVS Health
CVS
$120B
$118K ﹤0.01%
+1,400
New +$117K
MS icon
2862
PUT
Morgan Stanley
MS
$338B
$117K ﹤0.01%
+1,200
New +$119K
OXSQ icon
2863
Oxford Square Capital
OXSQ
$151M
$117K ﹤0.01%
+28,791
New +$131K
LYRA
2864
DELISTED
LYRA THERAPEUTICS INC
LYRA
$114K ﹤0.01%
249
-137
-35% -$51.8K
RMCO icon
2865
Royalty Management
RMCO
$48.1M
$114K ﹤0.01%
+11,524
New +$114K
CAAS icon
2866
China Automotive Systems
CAAS
$138M
$113K ﹤0.01%
34,614
-117,089
-77% -$459K
GTBP icon
2867
GT Biopharma
GTBP
$11.3M
$112K ﹤0.01%
553
-307
-36% -$92.4K
HPQ icon
2868
PUT
HP
HPQ
$26.6B
$112K ﹤0.01%
+4,100
New +$118K
RTB
2869
RTB Digital
RTB
$232M
$111K ﹤0.01%
+38
New +$127K
VNTR
2870
DELISTED
Venator Materials PLC
VNTR
$110K ﹤0.01%
+38,353
New +$123K
AXDX
2871
DELISTED
Accelerate Diagnostics
AXDX
$108K ﹤0.01%
+1,845
New +$120K
BHIL.WS
2872
CALL
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$107K ﹤0.01%
+14,994
New +$21.1K
ARAV
2873
DELISTED
Aravive, Inc. Common Stock
ARAV
$106K ﹤0.01%
28,462
-162,958
-85% -$696K
TARA icon
2874
Protara Therapeutics
TARA
$220M
$105K ﹤0.01%
15,190
-2,279
-13% -$17.8K
SIOX
2875
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$103K ﹤0.01%
+47,537
New +$103K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.04B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.